The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Proposal for the T Component for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 27 07 2023
revised: 17 08 2023
accepted: 20 08 2023
medline: 24 11 2023
pubmed: 28 8 2023
entrez: 27 8 2023
Statut: ppublish

Résumé

A TNM-based stage classification system of thymic epithelial tumors was adopted for the eighth edition of the stage classification of malignant tumors. The Thymic Domain of the Staging and Prognostics Factor Committee of the International Association for the Study of Lung Cancer developed a new database with the purpose to make proposals for the ninth edition stage classification system. This article outlines the proposed definitions for the T categories for the ninth edition TNM stage classification of thymic malignancies. A worldwide collective database of 11,347 patients with thymic epithelial tumors was assembled. Analysis was performed on 9147 patients with available survival data. Overall survival, freedom-from-recurrence, and cumulative incidence of recurrence were used as outcome measures. Analysis was performed separately for thymomas, thymic carcinomas, and neuroendocrine thymic tumors. Proposals for the T categories include the following: T1 category is divided into T1a (≤5 cm) and T1b (>5 cm), irrespective of mediastinal pleura invasion; T2 includes direct invasion of the pericardium, lung, or phrenic nerve; T3 denotes direct invasion of the brachiocephalic vein, superior vena cava, chest wall, or extrapericardial pulmonary arteries and veins; and T4 category remains the same as in the eighth edition classification, involving direct invasion of the aorta and arch vessels, intrapericardial pulmonary arteries and veins, myocardium, trachea, or esophagus. The proposed T categories for the ninth edition of the TNM classification provide good discrimination in outcome for the T component of the TNM-based stage system of thymic epithelial tumors.

Identifiants

pubmed: 37634808
pii: S1556-0864(23)00751-7
doi: 10.1016/j.jtho.2023.08.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1638-1654

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Meinoshin Okumura (M)

National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.

Mirella Marino (M)

IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Vanessa Cilento (V)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Emily Goren (E)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Enrico Ruffini (E)

University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it.

Daniel Dibaba (D)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Usman Ahmad (U)

Thoracic Surgery in the Heart, Vascular & Thoracic Institute at Cleveland Clinic, Abu Dhabi, United Arab Emirates.

Sarit Appel (S)

Sheba Medical Center, Ramat Gan, Israel.

Andrea Bille (A)

Guy's Hospital, London, United Kingdom.

Souheil Boubia (S)

University Hospital Ibn Rochd, Casablanca, Morocco.

Cecilia Brambilla (C)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Ayten Kayi Cangir (AK)

Ankara University Faculty of Medicine, Ankara, Turkey.

Frank Detterbeck (F)

Yale University School of Medicine, New Haven, Connecticut.

Conrad Falkson (C)

Queen's University in Kingston, Ontario, Canada.

Wentao Fang (W)

Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.

Pier Luigi Filosso (PL)

Baggiovara Civil Hospital, University of Modena, Modena, Italy.

Giuseppe Giaccone (G)

Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.

Nicolas Girard (N)

Institut Curie, Thorax Institute Curie Montsouris, Paris, France; Paris Saclay University, UVSQ, Versailles, France.

Francesco Guerrera (F)

University of Torino, Torino, Italy.

James Huang (J)

Memorial Sloan Kettering Cancer Center, New York, New York.

Maurizio Infante (M)

University and Hospital Trust, Verona, Italy.

Dong Kwan Kim (DK)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Marco Lucchi (M)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Edith M Marom (EM)

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.

Andrew G Nicholson (AG)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Ramon Rami-Porta (R)

Hospital Universitari Mutua Terrassa, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

Andreas Rimner (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Charles B Simone (CB)

Memorial Sloan Kettering Cancer Center, New York, New York.

Hisao Asamura (H)

Keio University, Tokyo, Japan; Present Address: Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH